1.	Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer Phase: Phase II, Phase I Type: Treatment Status: Active Age: Over 18 Sponsor: Pharmaceutical / Industry Protocol IDs: UCIRB #14735B, GV-001.010 (TNF-ELF), NCT00496236
2.	Use of Cone Beam Kilovaltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 06U.195, NCT00358007
3.	Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-050, NCT00713219
4.	A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: J0813, 1 R21 CA135635-01, NCT00894413
5.	A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 05C.255, NCT00329589
6.	Phase I Study Using Sunitinib Plus Radiation Therapy for Cancer Patients Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 06C.549, NCT00437372
7.	Phase I Pilot Study of Photodynamic Therapy Comprising HPPH in Patients Undergoing Surgery For Primary or Recurrent Squamous Cell Cancer of the Head and Neck Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: RPCI-I-74606, NCT00470496
8.	Four Doses of MAGE Vaccine for Patients With Squamous Cell Carcinoma of the Head and Neck Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: HP-41372, UMGCC 0804, NCT00704041
9.	Erlotinib Prior to Surgery in Patients With Head and Neck Cancer Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2008-0137, NCT00954226
10.	Prospective Pilot Study of Functional MRI Mapping and Brain Perfusion Imaging in Patients Undergoing Base of Skull and Brain Radiotherapy for Nonmetastatic Head and Neck Cancer Phase: Phase I Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: UPCC-808258, 808258, NCT00984074
11.	Phase I Study of Erlotinib Hydrochloride in Patients With Previously Treated Non-Small Cell Lung Cancer, Head and Neck Cancer, or Esophageal Cancer and Premalignant Lesions of the Lung Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 40 to 79 Sponsor: NCI Protocol IDs: NU-NWU08-11-01, NWU08-11-01, NCI-08-11-01, RPCI-I-121507, NCT01013831
12.	Molecular Classification of Head and Neck Tumors Using cDNA Microarray Analysis to Detect Prognosis and Response to Therapy Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Not specified Sponsor: NCI, Other Protocol IDs: 02-05-127E, NIH-R21-CA104402, NCT00200486
13.	A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy Phase: No phase specified Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 06-1210, NCT00608751
14.	A Pilot Study of the Use of the DaVinci Robotic System for Otorhinolaryngology-Head and Neck Surgery Phase: No phase specified Type: Health services research, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 07-03-080, NCT00627562
15.	STAT3 DECOY in Head and Neck Cancer Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UPCI 07-022, NCT00696176
16.	Pilot Study of Catheter-Based Ultrasound Hyperthermia Therapy After Brachytherapy in Patients With Urologic, Gynecologic, or Head and Neck Cancer Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: UCSF-08992, 08992, H10778-32056, NCT00911079